Brammer Biopharmaceuticals
2015
FOUNDED
M&A
STATUS
301-400
EMPLOYEES
Buyout/LBO
LATEST DEAL TYPE
1
FINANCING ROUNDS
1
INVESTMENTS
Description
Provider of best-in-class cell and gene therapy designed to improve patient health. The company's cell and gene therapy enabling pharmaceuticals and biotech clients to accelerate the delivery of novel medicines.
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Acquirer
Primary Office
- PO Box 267
- Lexington, MA 02420
- United States
Brammer Biopharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Brammer Biopharmaceuticals‘s full profile, request access.
Request full access to PitchBookBrammer Biopharmaceuticals Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 (0000000000 | 01-Jan-2017 | 000000000000000000 | Other Business Products and Services |